NCT07302776 2025-12-24TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCTStanford UniversityPhase 1 Not yet recruiting50 enrolled
NCT02129582 2021-05-07Targeted Marrow Irradiation, Fludarabine Phosphate, and Busulfan Before Donor Progenitor Cell Transplant in Treating Patients With Hematologic MalignanciesCase Comprehensive Cancer CenterPhase 1 Completed14 enrolled
NCT02167958 2019-10-15Nonmyeloablative Hematopoietic Cell Transplantation (HCT) for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Pilot Trial of Peripheral Blood Stem Cells (PBSC) as the Donor SourceUniversity of PittsburghPhase 1 Completed28 enrolled
NCT00513474 2017-05-25Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell TransplantMassachusetts General HospitalPhase 1 Completed46 enrolled 11 charts
NCT00104975 2016-12-15Alemtuzumab and Combination Chemotherapy Followed By Donor Lymphocytes in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic CancerYale UniversityPhase 1 Completed20 enrolled
NCT00004904 2012-06-04Stem Cell Transplantation in Treating Patients With Hematologic CancerNorthwestern UniversityPhase 1 Completed